An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder.
Phase of Trial: Phase III
Latest Information Update: 31 May 2016
At a glance
- Drugs Imidafenacin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Sponsors Ono Pharmaceutical
- 17 Jun 2009 Actual end date (1 May 2009) and actual patient number (435) added as reported by ClinicalTrials.gov.
- 17 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Jun 2008 The expected completion date for this trial is now 1 Apr 2009 as reported by ClinicalTrials.gov.